Ghent University Academic Bibliography

Your filters: cql: affiliation exact FW cql: author exact 801000832742

Add to list
Complementary role of fractional exhaled nitric oxide and blood eosinophil counts in asthma prevalence and diagnosis : sex-specific evidence from NHANES

Sebastian Riemann (UGent) , Andrei Malinovschi and Guy Brusselle (UGent)

(2025) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In American Journal of Respiratory and Critical Care Medicine 211(Supplement S).
Add to list
- Journal Article
- A1
- open access
Roads to remission : evolving treatment concepts in type 2 inflammatory diseases

Marek Lommatzsch, Katharina Blumchen, Lisa A. Beck, Jean Bousquet, Guy Brusselle (UGent) , Wytske J. Fokkens, Eckard Hamelmann, Susanne Lau, Hagen Ott, Oliver Pfaar, et al.

(2025) ECLINICALMEDICINE. 80.
Add to list
- Journal Article
- A1
- open access
Chronic cough and chronic pruritus in older adults : a population-based cross-sectional study

Juliette Bollemeijer, Sebastian Riemann (UGent) , Hok Bing Thio, Tamar E.C. Nijsten, Guy Brusselle (UGent) and Luba M. Pardo

(2025) ERJ OPEN RESEARCH.
Add to list
- Journal Article
- A1
- open access
Dupilumab induces long-term on-treatment clinical remission in patients with type 2 asthma

Ian D. Pavord, Klaus F. Rabe, Elliot Israel, Stanley J. Szefler, Guy Brusselle (UGent) , Nami Pandit-Abid, Arman Altincatal, Zhen Chen, Nikhil Amin, Asif H. Khan, et al.

(2025) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 13(1). p.132-142
Add to list
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints : opportunities and challenges

Job F M van Boven, Richard W Costello, Kit C B Roes, Guy Brusselle (UGent) , Kjeld Hansen, Jerry A Krishnan, Christopher E Brightling, Nicolas Roche, Salman Siddiqui, Bruce J Kirenga, et al.

(2025) LANCET RESPIRATORY MEDICINE. 13(2). p.177-188
Add to list
- Miscellaneous
Preserved ratio impaired spirometry (PRISm) : prognostic, preventable and treatable?

Guy Brusselle (UGent) and Sebastian Riemann (UGent)

(2025) THORAX. 80(4). p.195-196
Add to list
- Journal Article
- A1
- open access
Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution

Joyceline De Volder (UGent) , Annelies Bontinck, Valerie Haelterman (UGent) , Louis Boon, Guy Joos (UGent) , Guy Brusselle (UGent) and Tania Maes (UGent)

(2025) RESPIRATORY RESEARCH. 26(1).
Add to list
- Journal Article
- A1
- open access
Biologics and airway remodeling in asthma : early, late, and potential preventive effects

G. Varricchi, R. Poto, M. Lommatzsch, Guy Brusselle (UGent) , F. Braido, J. C. Virchow and G. W. Canonica

(2025) ALLERGY. 80(2). p.408-422
Add to list
- Journal Article
- A2
- open access
Prospective REALITI-A study : 2-year real-world benefits of mepolizumab in severe asthma

Cristiano Caruso, G. Walter Canonica, Manish Patel, Andrew Smith, Mark C. Liu, Rafael Alfonso-Cristancho, Robert G. Price, Rupert W. Jakes, Lydia Demetriou, Antonio Valero, et al.

(2025) CHEST PULMONARY. 3(1).
Add to list
- Journal Article
- A2
- open access
Relapse of eosinophilic granulomatosis with polyangiitis (EGPA) despite maintenance treatment with low-dose mepolizumab

Aurelie Vanthuyne, Sebastian Riemann (UGent) and Guy Brusselle (UGent)

(2025) RESPIROLOGY CASE REPORTS. 13(5).

Academic Bibliography

Complementary role of fractional exhaled nitric oxide and blood eosinophil counts in asthma prevalence and diagnosis : sex-specific evidence from NHANES

Roads to remission : evolving treatment concepts in type 2 inflammatory diseases

Chronic cough and chronic pruritus in older adults : a population-based cross-sectional study

Dupilumab induces long-term on-treatment clinical remission in patients with type 2 asthma

Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints : opportunities and challenges

Preserved ratio impaired spirometry (PRISm) : prognostic, preventable and treatable?

Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution

Biologics and airway remodeling in asthma : early, late, and potential preventive effects

Prospective REALITI-A study : 2-year real-world benefits of mepolizumab in severe asthma

Relapse of eosinophilic granulomatosis with polyangiitis (EGPA) despite maintenance treatment with low-dose mepolizumab

Contents

Support

Contact